These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 11422102)
1. Thyroid cancer in the UK: can we do it better? Kendall-Taylor P Clin Endocrinol (Oxf); 2001 Jun; 54(6):705-6. PubMed ID: 11422102 [No Abstract] [Full Text] [Related]
2. Extent of surgery for differentiated thyroid cancer. Dackiw AP; Zeiger M Surg Clin North Am; 2004 Jun; 84(3):817-32. PubMed ID: 15145237 [TBL] [Abstract][Full Text] [Related]
3. Well differentiated thyroid cancer: are we over treating our patients? Nixon IJ; Shah JP Eur J Surg Oncol; 2014 Feb; 40(2):129-32. PubMed ID: 24373300 [No Abstract] [Full Text] [Related]
7. Postoperative radioactive iodine-131 ablation is not necessary among patients with intermediate-risk differentiated thyroid carcinoma: a population-based study. Zhang H; Cai Y; Zheng L; Zhang Z; Jiang N Hell J Nucl Med; 2017; 20(1):3-10. PubMed ID: 28315902 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of 131I ablation following thyroidectomy in patients with invasive follicular thyroid cancer. Davis NL; Gordon M; Germann E; McGregor GI; Robins RE Am J Surg; 1992 May; 163(5):472-5. PubMed ID: 1575301 [TBL] [Abstract][Full Text] [Related]
10. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy? Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181 [TBL] [Abstract][Full Text] [Related]
11. Do Lower-Risk Thyroid Cancer Patients Who Live in Regions with More Aggressive Treatments Have Better Outcomes? Hall SF; Irish J; Groome P; Griffiths R; Hurlbut D Thyroid; 2017 Oct; 27(10):1246-1257. PubMed ID: 28851261 [TBL] [Abstract][Full Text] [Related]
13. Management and outcome of recurrent well-differentiated thyroid carcinoma. Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757 [TBL] [Abstract][Full Text] [Related]
14. [Therapy and survival in thyroid tumors]. Rodari A Minerva Med; 1986 Nov; 77(44):2127-30. PubMed ID: 3785730 [No Abstract] [Full Text] [Related]
15. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine. Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968 [TBL] [Abstract][Full Text] [Related]
16. New therapeutic approach for mixed anaplastic carcinoma of the thyroid. St Cyr JA; Shearen J; Delaney JP Minn Med; 1985 Dec; 68(12):893, 895-6, 901. PubMed ID: 4088180 [No Abstract] [Full Text] [Related]
17. I-131 uptake demonstrated in the appendix on a posttreatment scan in a patient with thyroid cancer. Borkar S; Grewal R; Schoder H Clin Nucl Med; 2008 Aug; 33(8):551-2. PubMed ID: 18645376 [No Abstract] [Full Text] [Related]
18. Papillary microcarcinoma of the thyroid. Shaha AR; Tuttle RM; Shah JP J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917 [No Abstract] [Full Text] [Related]
19. Radioiodine therapy and age at menopause in patients with thyroid cancer. Rosario PW; Fagundes TA; Fagundes AV; Barraso AL; Rezende LL; Padrao EL; Guimaraes VC; Purisch S Clin Endocrinol (Oxf); 2006 Feb; 64(2):225-6. PubMed ID: 16430725 [No Abstract] [Full Text] [Related]